DE69031355T2 - Verwendung von Human-Beta-Interferon zur Stimulierung der Erythropoiesis - Google Patents

Verwendung von Human-Beta-Interferon zur Stimulierung der Erythropoiesis

Info

Publication number
DE69031355T2
DE69031355T2 DE69031355T DE69031355T DE69031355T2 DE 69031355 T2 DE69031355 T2 DE 69031355T2 DE 69031355 T DE69031355 T DE 69031355T DE 69031355 T DE69031355 T DE 69031355T DE 69031355 T2 DE69031355 T2 DE 69031355T2
Authority
DE
Germany
Prior art keywords
human beta
beta interferon
stimulate erythropoiesis
erythropoiesis
stimulate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69031355T
Other languages
English (en)
Other versions
DE69031355D1 (de
Inventor
Rita Michalevicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Interpharm Laboratories Ltd
Original Assignee
Ramot at Tel Aviv University Ltd
Interpharm Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd, Interpharm Laboratories Ltd filed Critical Ramot at Tel Aviv University Ltd
Application granted granted Critical
Publication of DE69031355D1 publication Critical patent/DE69031355D1/de
Publication of DE69031355T2 publication Critical patent/DE69031355T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69031355T 1989-03-19 1990-03-15 Verwendung von Human-Beta-Interferon zur Stimulierung der Erythropoiesis Expired - Lifetime DE69031355T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL89662A IL89662A (en) 1989-03-19 1989-03-19 Pharmaceutical compositions comprising interferon-beta

Publications (2)

Publication Number Publication Date
DE69031355D1 DE69031355D1 (de) 1997-10-09
DE69031355T2 true DE69031355T2 (de) 1998-01-08

Family

ID=11059803

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69034076T Expired - Lifetime DE69034076T2 (de) 1989-03-19 1990-03-15 Verwendung von Human-Beta-Interferon zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von chronischer Myeloidleukämie
DE69031355T Expired - Lifetime DE69031355T2 (de) 1989-03-19 1990-03-15 Verwendung von Human-Beta-Interferon zur Stimulierung der Erythropoiesis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69034076T Expired - Lifetime DE69034076T2 (de) 1989-03-19 1990-03-15 Verwendung von Human-Beta-Interferon zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von chronischer Myeloidleukämie

Country Status (12)

Country Link
US (1) US5104653A (de)
EP (2) EP0643973B1 (de)
JP (1) JP2883669B2 (de)
AT (2) ATE240116T1 (de)
AU (1) AU619960B2 (de)
CA (1) CA2011992C (de)
DE (2) DE69034076T2 (de)
DK (2) DK0388799T3 (de)
ES (2) ES2107414T3 (de)
GR (1) GR3024763T3 (de)
IL (1) IL89662A (de)
ZA (1) ZA901994B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
JP4066460B2 (ja) * 1995-07-25 2008-03-26 東レ株式会社 骨疾患治療薬
AU2591699A (en) * 1998-02-09 1999-08-23 University Of Southern California Method of promoting erythropoiesis
AU3070702A (en) * 2000-11-07 2002-05-21 Chiron Corp Stabilized inteferon compositions
ES2234928T3 (es) * 2000-11-14 2005-07-01 Universite Libre De Bruxelles Generacion y uso de celulas dendriticas.
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US8084424B2 (en) * 2003-04-09 2011-12-27 University Of Utah Research Foundation Compositions and methods related to erythropoietin
MXPA06008496A (es) 2004-02-02 2007-01-30 Ambrx Inc Polipeptidos de interferon humano modificados y sus usos.
EP1746882A4 (de) * 2004-03-31 2010-08-25 Nitromed Inc Verfahren zur behandlung von blutkrankheiten mit stickoxid-donorverbindungen
WO2007097951A2 (en) * 2006-02-17 2007-08-30 Nitromed, Inc. Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460574A (en) * 1980-06-16 1984-07-17 Yabrov Alexander A Prophylaxis or treatment of interferon-sensitive diseases
GB8412564D0 (en) * 1984-05-17 1984-06-20 Searle & Co Structure and properties
CA1294215C (en) * 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US4851219A (en) * 1986-11-18 1989-07-25 Genentech, Inc. Method for the treatment of chronic myelogenous leukemia
AU2855189A (en) * 1988-01-25 1989-07-27 Baker Cummins Dermatologicals, Inc. Method of treating fibrotic disorders

Also Published As

Publication number Publication date
DE69034076D1 (de) 2003-06-18
EP0388799A3 (de) 1991-07-31
DK0388799T3 (da) 1998-03-30
AU619960B2 (en) 1992-02-06
EP0388799B1 (de) 1997-09-03
JP2883669B2 (ja) 1999-04-19
ZA901994B (en) 1990-12-28
ES2107414T3 (es) 1997-12-01
ATE157544T1 (de) 1997-09-15
ATE240116T1 (de) 2003-05-15
EP0643973A1 (de) 1995-03-22
CA2011992C (en) 2003-04-29
ES2198409T3 (es) 2004-02-01
DK0643973T3 (da) 2003-09-08
EP0388799A2 (de) 1990-09-26
CA2011992A1 (en) 1990-09-19
IL89662A (en) 1997-11-20
US5104653A (en) 1992-04-14
DE69031355D1 (de) 1997-10-09
DE69034076T2 (de) 2003-11-20
AU5144590A (en) 1990-09-20
JPH0314523A (ja) 1991-01-23
IL89662A0 (en) 1989-09-28
GR3024763T3 (en) 1997-12-31
EP0643973B1 (de) 2003-05-14

Similar Documents

Publication Publication Date Title
DE69031355D1 (de) Verwendung von Human-Beta-Interferon zur Stimulierung der Erythropoiesis
SE8500460D0 (sv) Nya 6-substituerade furo-(3,4-c)-pyridin-derivat, sett for deras framstellning och terapeutiska kompositioner, innehallande foreningarna
DE69007744D1 (de) Verwendung von Interleukin 2 zur Behandlung von Leukämien.
DK49488A (da) Anaestesi-praeparat
NZ227944A (en) Synergistic pharmaceutical composition of a hybrid interferon and a muramylpeptide
DE69010294T2 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
FI863078A0 (fi) Kontinuerligt frigoerande peptidkompositioner.
DK328088D0 (da) Farmaceutisk komposition til behandling af tumorer
IE871358L (en) Interferon for carcinoma
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
FI863079A (fi) Kontinuerligt frigoerande fenyletanolaminderivatkompositioner.
ATE74517T1 (de) Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
IT8714753V0 (it) Accorgimenti per la regolazione del rocher nelle tavole da windsurf

Legal Events

Date Code Title Description
8364 No opposition during term of opposition